Skip to content
Screener

Agilon Health AGL Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$1.6BBeat by $100.6M
EPS-$11.50Miss by $4.75
Revenue estimate$1.5B
EPS estimate-$6.75

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$1.5B
EPS estimate-$1.22

Financials

Q4 2025

Income statement

See full
Revenue$1.6B+3.1%
Operating income-$193.8M-79.3%
Net income-$188.9M-78.5%
EPS (diluted)-$0.46-76.9%

Balance sheet

See full
Cash & equivalents$173.7M-10.4%
Total debt$36.8M-16.3%
Total equity$126.7M-73.1%
Total assets$1.3B-26.7%

Cash flow

See full
Operating cash flow-$20.5M—
CapEx$3.0M-9.1%
Free cash flow-$23.5M—

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$285.52M-63.5%
Enterprise value$148.62M-76.5%
P/S0×-0.1×

Profitability

See full
Operating margin-7.8%+12.7pp
Net margin-6.6%+7.6pp
FCF margin-2%—

Returns & leverage

See full
Return on equity-131%-285pp
Debt / equity0.3×+0.2×
Current ratio1×-0.2×

Segments

By product

See full
Medical services revenue$1.6B+3.1%
Other operating revenue$2.5M-22.7%

FAQ

When did Agilon Health report Q4 2025 earnings?
Agilon Health (AGL) reported Q4 2025 earnings on February 25, 2026 after market close.
What were Agilon Health's Q4 2025 revenue and EPS?
Agilon Health reported revenue of $1.6B and eps of $-11.50 for Q4 2025.
Did Agilon Health beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.5B by $100.6M. EPS missed the consensus estimate of $-6.75 by $4.75.
How did Agilon Health's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.1% from $1.5B a year earlier and eps declined 4500.0% from $-0.25.
Where can I find Agilon Health's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-011630) and the 10-K periodic report (0001628280-26-011655) directly on SEC EDGAR. The filing index links above go to sec.gov.